Age (years) | Â | Â |
 | Median (range) | 72 (53–77) |
Follow-up (mos) | Â | Â |
 | Median (range) | 71 (32.8-93.6) |
Stage (N /%) | Â | Â |
 | T1c | 1 (2.5%) |
T2a | 11 (28%) | |
T2b | 15 (38.5%) | |
T2c | 12 (31%) | |
Gleason score | Â | Â |
 | <=6 | 13 (33.3%) |
7 (3 + 4) | 20 (51.3%) | |
7 (4 + 3) | 6 (15.4%) | |
% Biopsy core | Â | Â |
 | 0-24% | 12 (31%) |
25-49% | 16 (41%) | |
50-74% | 10 (26%) | |
75-100% | 1 (2%) | |
iPSA | Â | Â |
 | <10 | 37 (95%) |
 | 10–19.9 | 2 (5%) |